A method for improving the accuracy of non-invasive prenatal screening by cell-free foetal DNA size selection.
Conclusion cfDNA size selection is an important step in improving the accuracy of non-invasive prenatal screening for chromosomal abnormalities.
PMID: 29968522 [PubMed - in process]
Source: British Journal of Biomedical Science - Category: Laboratory Medicine Tags: Br J Biomed Sci Source Type: research
More News: Amniocentesis | Babies | Biomedical Science | Laboratory Medicine | Pregnancy | Science | UK Health | Women